Global CAR T Cell Therapy Market Report By Targeted Antigen (CD 19, CD 20, GD2, CD22, CD30, CD33, HER1, HER2, Meso, Egfrvlll And Others), By Therapeutic Application (Acute Lymphocytic Leukemia, Chronic Lymphocytic Leukemia, Non Hodgkin Leukemia, Multiple Myeloma, Pancreatic Cancer, Neuroblasta, Breast Cancer, Acute Myeloid Leukemia, Hepatocellular, Carcinoma, Colorectal Cancer And Others) And By Regions - Industry Trends, Size, Share, Growth, Estimation And Forecast, 2019-2026
ID:VMR11210077
January 2020
Report Formats:

As per this study the Global CAR T Cell Therapy Market was valued USD XXX MN (by revenue) in 2019 and is anticipated to reach USD X,XXX.X MN by 2026 with a CAGR of XX%.
 
CAR T-cell therapy refers to the type of cancer treatment by injecting T-cells engineered with Chimeric Antigen Receptor (CAR) protein.  It includes infusion of engineered T cells to attack the tumor or carcinogenic cells. Basically, in this therapy, T-cells are collected, re-engineered in the laboratory with CAR protein and reinfused in the patient’s body. These T cells now act as an attacker on the tumor-causing cells. CAR T cell therapy is used in curing patients with breast cancer, pancreas cancer, colorectal cancer and various types of blood cancer.

 Market Dynamics
 
Rising prevalence of cancer coupled with high demand for effective treatment to cure cancer is driving the market growth. Technological advancement for advanced and reliable treatment for cancer is fueling the market growth. Growing number of patients immune to chemotherapy and radiations is opening new avenues for growth of CAR T cell therapy market. Governmental initiatives on treatment and research on combating cancer are boosting market growth. On the flip side, side effects leading to neurological problems coupled with high treatment cost are likely to restrain the market growth.
 
This detailed market study is centered on the data obtained from multiple sources and is analyzed using numerous tools including porter’s five forces analysis, market attractiveness analysis and value chain analysis. These tools are employed to gain insights of the potential value of the market facilitating the business strategists with the latest growth opportunities. Additionally, these tools also provide a detailed analysis of each application/product segment in the global market of CAR T cell therapy.
 
Market Segmentation
 
The broad CAR T cell therapy market has been sub-grouped into target antigen and therapeutic application. The report studies these subsets with respect to the geographical segmentation. The strategists can gain a detailed insight and devise appropriate strategies to target specific market. This detail will lead to a focused approach leading to identification of better opportunities.
 
By Target Antigen

  • CD 19
  • CD 20
  • GD2
  • CD22
  • CD30
  • CD33
  • HER1
  • HER2
  • Meso
  • Egfrvlll
  • Others
 
By Therapeutic Application
  • Acute Lymphocytic Leukemia
  • Chronic Lymphocytic Leukemia
  • Non Hodgkin Leukemia
  • Multiple Myeloma
  • Pancreatic Cancer
  • Neuroblasta
  • Breast Cancer
  • Acute Myeloid Leukemia
  • Hepatocellular
  • Carcinoma
  • Colorectal Cancer
  • Others
 
Regional Analysis
 
Furthermore, the report comprises of the geographical segmentation which mainly focuses on current and forecast demand for CAR T cell therapy in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The report further focuses on demand for individual application segments in all the regions.
 
Europe CAR T Cell Therapy Market By Revenue (USD MN)
 

 
The report also covers detailed competitive landscape including company profiles of key players operating in the global market. The key players in the CAR T cell therapy market include Bellicum Pharmaceuticals, Inc., Celgene Corporation, Cellectis, Juno Therapeutics, Kite Pharma Inc., Novartis International AG and Sorrento Therapeutics, Inc. An in-depth view of the competitive outlook includes future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launches, new product developments and other developments with information in terms of H.Q.
 
METHODOLOGY:
 
A combination of primary and secondary research has been used to determine the market estimates and forecasts. Sources used for secondary research include (but not limited to) Paid Data Sources, Company Websites, Technical Journals, Annual Reports, SEC Filings and various other industry publications. Specific details on methodology used for this report can be provided on demand. 

1 . PREFACE
       1.1. Report Description
           1.1.1. Objective
           1.1.2. Target Audience
           1.1.3. Unique Selling Proposition (USP) & offerings
       1.2. Research Scope
       1.3. Research Methodology
           1.3.1. Market Research Process
           1.3.2. Market Research Methodology
 
2 . EXECUTIVE SUMMARY
       2.1. Highlights of Car T Cell Therapy Market
       2.2. Global Car T Cell Therapy Market Snapshot
 
3 . CAR T CELL THERAPY – INDUSTRY ANALYSIS
       3.1. Introduction
       3.2. Market Drivers of Car T Cell Therapy Market
       3.3. Market Restraints of Car T Cell Therapy Market
       3.4. Opportunities of Car T Cell Therapy Market
       3.5. Trends of Car T Cell Therapy Market
       3.6. Porter’s Five Force Analysis of Car T Cell Therapy Market
       3.7. Car T Cell Therapy Market Attractiveness Analysis
           3.7.1 Market Attractive Analysis by Target Antigen
           3.7.2 Market Attractive Analysis by Therapeutic Application
           3.7.3 Market Attractive Analysis by Region
 
4 . VALUE CHAIN ANALYSIS
       4.1. Car T Cell Therapy Value Chain Analysis
       4.2. Car T Cell Therapy Raw Material Analysis
           4.2.1. List of Raw Materials
           4.2.2. Car T Cell Therapy Raw Material Manufactures List
           4.2.3. Price Trend of Car T Cell Therapy Key Raw Materials
       4.3. List of Potential Buyers
       4.4. Marketing Channel
           4.4.1. Direct Marketing
           4.4.2. Indirect Marketing
           4.4.3. Marketing Channel Development Trend
 
5 . GLOBAL CAR T CELL THERAPY MARKET ANALYSIS BY TARGET ANTIGEN
       5.1 Overview by Target Antigen
       5.2 Global Car T Cell Therapy Market Analysis by Target Antigen
       5.3 Market Analysis of CD 19 by Regions
       5.4 Market Analysis of CD 20 by Regions
       5.5 Market Analysis of GD2 by Regions
       5.6 Market Analysis of CD22 by Regions
       5.7 Market Analysis of CD30 by Regions
       5.8 Market Analysis of CD33 by Regions
       5.9 Market Analysis of HER1 by Regions
       5.10. Market Analysis of HER2 by Regions
       5.11 Market Analysis of Meso by Regions
       5.12 Market Analysis of Egfrvlll by Regions
       5.13 Market Analysis of Others by Regions
 
6 . GLOBAL CAR T CELL THERAPY MARKET ANALYSIS BY THERAPEUTIC APPLICATION
       6.1 Overview by Therapeutic Application
       6.2 Global Car T Cell Therapy Market Analysis by Therapeutic Application
       6.3 Market Analysis of Acute Lymphocytic Leukemia by Regions
       6.4 Market Analysis of Chronic Lymphocytic Leukemia by Regions
       6.5 Market Analysis of Non Hodgkin Leukemia by Regions
       6.6 Market Analysis of Multiple Myeloma by Regions
       6.7 Market Analysis of Pancreatic Cancer by Regions
       6.8 Market Analysis of Neuroblasta by Regions
       6.9 Market Analysis of Breast Cancer by Regions
       6.10. Market Analysis of Acute Myeloid Leukemia by Regions
       6.11 Market Analysis of Hepatocellular by Regions
       6.12 Market Analysis of Carcinoma by Regions
       6.13 Market Analysis of Colorectal Cancer by Regions
 
7 . GLOBAL CAR T CELL THERAPY MARKET ANALYSIS BY GEOGRAPHY
       7.1. Regional Outlook
       7.2. Introduction
       7.3. North America
           7.3.1. Overview
           7.3.2. North America Car T Cell Therapy Market Estimate by Market Segment
           7.3.3. North America Car T Cell Therapy Market Estimate by Country
           7.3.4. United State
           7.3.5. Rest of North America
       7.4. Europe
           7.4.1. Overview
           7.4.2. Europe Car T Cell Therapy Market Estimate by Market Segment
           7.4.3. Europe Car T Cell Therapy Market Estimate by Country
           7.4.4. United Kingdom
           7.4.5. France
           7.4.6. Germany
           7.4.7 Rest of Europe
       7.5. Asia Pacific
           7.5.1. Overview
           7.5.2. Asia Pacific Car T Cell Therapy Market Estimate by Market Segment
           7.5.3. Asia Pacific Car T Cell Therapy Market Estimate by Country
           7.5.4. China
           7.5.5. Japan
           7.5.6. India
           7.5.7. Rest of Asia Pacific
       7.6. Latin America
           7.6.1. Overview
           7.6.2. Latin America Car T Cell Therapy Market Estimate by Market Segment
           7.6.3. Latin America Car T Cell Therapy Market Estimate by Country
           7.6.4. Brazil
           7.6.5. Rest of Latin America
       7.7. Middle East & Africa
           7.7.1. Overview
           7.7.2. Middle East & Africa Car T Cell Therapy Market Estimate by Market Segment
           7.7.3. Middle East & Africa Car T Cell Therapy Market Estimate by Country
           7.7.4. Middle East
           7.7.5. Africa
 
8 . COMPETITIVE LANDSCAPE OF THE CAR T CELL THERAPY COMPANIES
       8.1. Car T Cell Therapy Market Competition
       8.2. Partnership/Collaboration/Agreement
       8.3. Merger And Acquisitions
       8.4. New Product Launch
       8.5. Other Developments
 
9 . COMPANY PROFILES OF CAR T CELL THERAPY INDUSTRY
       9.1. Company Share Analysis
       9.2. Market Concentration Rate
       9.3. Bellicum Pharmaceuticals, Inc.
           9.3.1. Company Overview
           9.3.2. Financials
           9.3.3. Products
           9.3.4. Recent Developments
       9.4. Celgene Corporation
           9.4.1. Company Overview
           9.4.2. Financials
           9.4.3. Products
           9.4.4. Recent Developments
       9.5. Cellectis
           9.5.1. Company Overview
           9.5.2. Financials
           9.5.3. Products
           9.5.4. Recent Developments
       9.6. Juno Therapeutics
           9.6.1. Company Overview
           9.6.2. Financials
           9.6.3. Products
           9.6.4. Recent Developments
       9.7. Kite Pharma Inc.
           9.7.1. Company Overview
           9.7.2. Financials
           9.7.3. Products
           9.7.4. Recent Developments
       9.8. Novartis International AG
           9.8.1. Company Overview
           9.8.2. Financials
           9.8.3. Products
           9.8.4. Recent Developments
       9.9. Sorrento Therapeutics, Inc.
           9.9.1. Company Overview
           9.9.2. Financials
           9.9.3. Products
           9.9.4. Recent Developments
 
10.  IMPACT ANALYSIS OF COVID-19 OUTBREAK
       10.1. Impact Analysis of Covid-19 Outbreak on the Market
           10.1.1. Direct Impact on Production
           10.1.2. Supply Chain and Market Disruption
           10.1.3. Financial Impact on Firms and Financial Markets
       10.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
       10.3. Pre V/S Post COVID-19 Market
       10.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Market Size in 2020, by Scenario
       10.5. COVID-19: Micro and Macro Factor Analysis on the Market
    
 *Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies
 
LIST OF TABLES

  •  Global Market Snapshot
  •  Drivers of the Global Market Impact Analysis
  •  Restraints of the Global Market Impact Analysis
  •  List of Raw Material
  •  List of Raw Material Manufactures
  •  List of Potential Buyers 
  •  COVID-19 Impact Analysis by Production, Import, Export and Demand
  •  Pre V/S Post COVID-19 Market
  •  Estimated Impact Of The Coronavirus (Covid-19) Epidemic On The Market Size In 2020, By Scenario
  •  COVID-19: Micro and Macro Factor Analysis on the Market
  •  Global Car T Cell Therapy Market Analysis by Target Antigen (USD MN)
  •  Global Car T Cell Therapy Market Analysis in HER1 by Geography (USD MN)
  •  Global Car T Cell Therapy Market Analysis in HER2 by Geography (USD MN)
  •  Global Car T Cell Therapy Market Analysis in Meso by Geography (USD MN)
  •  Global Car T Cell Therapy Market Analysis in Egfrvlll by Geography (USD MN)
  •  Global Car T Cell Therapy Market Analysis in Others by Geography (USD MN)
  •  Global Car T Cell Therapy Market Analysis by Therapeutic Application (USD MN)
  •  Global Car T Cell Therapy Market Analysis in Acute Lymphocytic Leukemia by Geography (USD MN)
  •  Global Car T Cell Therapy Market Analysis in Chronic Lymphocytic Leukemia by Geography (USD MN)
  •  Global Car T Cell Therapy Market Analysis in Non Hodgkin Leukemia by Geography (USD MN)
  •  Global Car T Cell Therapy Market Analysis in Multiple Myeloma by Geography (USD MN)
  •  Global Car T Cell Therapy Market Analysis in Pancreatic Cancer by Geography (USD MN)
  •  Global Car T Cell Therapy Market Analysis in Neuroblasta by Geography (USD MN)
  •  Global Car T Cell Therapy Market Analysis in Breast Cancer by Geography (USD MN)
  •  Global Car T Cell Therapy Market Analysis in Acute Myeloid Leukemia by Geography (USD MN)
  •  Global Car T Cell Therapy Market Analysis in Hepatocellular by Geography (USD MN)
  •  Global Car T Cell Therapy Market Analysis in Carcinoma by Geography (USD MN)
  •  Global Car T Cell Therapy Market Analysis in Colorectal Cancer by Geography (USD MN)
  •  Global Car T Cell Therapy Market by Geography (USD MN)
  •  North America Car T Cell Therapy Market Analysis by Target Antigen (USD MN)
  •  North America Car T Cell Therapy Market Estimate by Therapeutic Application (USD MN)
  •  North America Car T Cell Therapy Market Estimate by Country (USD MN)
  •  United State Car T Cell Therapy Market Analysis by Target Antigen (USD MN)
  •  United State Car T Cell Therapy Market Estimate by Therapeutic Application (USD MN)
  •  Rest of North America Car T Cell Therapy Market Analysis by Target Antigen (USD MN)
  •  Rest of North America Car T Cell Therapy Market Estimate by Therapeutic Application (USD MN)
  •  Europe Car T Cell Therapy Market Analysis by Target Antigen (USD MN)
  •  Europe Car T Cell Therapy Market Estimate by Therapeutic Application (USD MN)
  •  United Kingdom Car T Cell Therapy Market Analysis by Target Antigen (USD MN)
  •  United Kingdom Car T Cell Therapy Market Estimate by Therapeutic Application (USD MN)
  •  France Car T Cell Therapy Market Analysis by Target Antigen (USD MN)
  •  France Car T Cell Therapy Market Estimate by Therapeutic Application (USD MN)
  •  Germany Car T Cell Therapy Market Analysis by Target Antigen (USD MN)
  •  Germany Car T Cell Therapy Market Estimate by Therapeutic Application (USD MN)
  •  Rest of Europe Car T Cell Therapy Market Analysis by Target Antigen (USD MN)
  •  Rest of Europe Car T Cell Therapy Market Estimate by Therapeutic Application (USD MN)
  •  Asia Pacific Car T Cell Therapy Market Analysis by Target Antigen (USD MN)
  •  Asia Pacific Car T Cell Therapy Market Estimate by Therapeutic Application (USD MN)
  •  Asia Pacific Car T Cell Therapy Market Estimate by Country (USD MN)
  •  China Car T Cell Therapy Market Analysis by Target Antigen (USD MN)
  •  China Car T Cell Therapy Market Estimate by Therapeutic Application (USD MN)
  •  Japan Car T Cell Therapy Market Analysis by Target Antigen (USD MN)
  •  Japan Car T Cell Therapy Market Estimate by Therapeutic Application (USD MN)
  •  India Car T Cell Therapy Market Analysis by Target Antigen (USD MN)
  •  India Car T Cell Therapy Market Estimate by Therapeutic Application (USD MN)
  •  Rest of Asia Pacific Car T Cell Therapy Market Analysis by Target Antigen (USD MN)
  •  Rest of Asia Pacific Car T Cell Therapy Market Estimate by Therapeutic Application (USD MN)
  •  Latin America Car T Cell Therapy Market Analysis by Target Antigen (USD MN)
  •  Latin America Car T Cell Therapy Market Estimate by Therapeutic Application (USD MN)
  •  Latin America Car T Cell Therapy Market Estimate by Country (USD MN)
  •  Brazil Car T Cell Therapy Market Analysis by Target Antigen (USD MN)
  •  Brazil Car T Cell Therapy Market Estimate by Therapeutic Application (USD MN)
  •  Rest of Latin America Car T Cell Therapy Market Analysis by Target Antigen (USD MN)
  •  Rest of Latin America Car T Cell Therapy Market Estimate by Therapeutic Application (USD MN)
  •  Middle East & Africa Car T Cell Therapy Market Analysis by Target Antigen (USD MN)
  •  Middle East & Africa Car T Cell Therapy Market Estimate by Therapeutic Application (USD MN)
  •  Middle East & Africa Car T Cell Therapy Market Estimate by Country (USD MN)
  •  Middle East Car T Cell Therapy Market Analysis by Target Antigen (USD MN)
  •  Middle East Car T Cell Therapy Market Estimate by Therapeutic Application (USD MN)
  •  Africa Car T Cell Therapy Market Analysis by Target Antigen (USD MN)
  •  Africa Car T Cell Therapy Market Estimate by Therapeutic Application (USD MN)
  •  Partnership/Collaboration/Agreement
  •  Mergers And Acquisiton
  •  New Product Launch
  •  Other Developments
  •  Company Market Share Analysis, 2019
 
 LIST OF FIGURES
 
  •  Research Scope of Car T Cell Therapy Report
  •  Market Research Process
  •  Market Research Methodology
  •  Global Car T Cell Therapy Market Size, by Region (USD MN)
  •  Porters Five Forces Analysis
  •  Market Attractiveness Analysis by Target Antigen
  •  Market Attractiveness Analysis by Therapeutic Application
  •  Market Attractiveness Analysis by Region
  •  Value Chain Analysis
  •  Global Car T Cell Therapy Market Analysis by Target Antigen (USD MN)
  •  Global Car T Cell Therapy Market Analysis in HER1 by Geography (USD MN)
  •  Global Car T Cell Therapy Market Analysis in HER2 by Geography (USD MN)
  •  Global Car T Cell Therapy Market Analysis in Meso by Geography (USD MN)
  •  Global Car T Cell Therapy Market Analysis in Egfrvlll by Geography (USD MN)
  •  Global Car T Cell Therapy Market Analysis in Others by Geography (USD MN)
  •  Global Car T Cell Therapy Market Analysis by Therapeutic Application (USD MN)
  •  Global Car T Cell Therapy Market Analysis in Acute Lymphocytic Leukemia by Geography (USD MN)
  •  Global Car T Cell Therapy Market Analysis in Chronic Lymphocytic Leukemia by Geography (USD MN)
  •  Global Car T Cell Therapy Market Analysis in Non Hodgkin Leukemia by Geography (USD MN)
  •  Global Car T Cell Therapy Market Analysis in Multiple Myeloma by Geography (USD MN)
  •  Global Car T Cell Therapy Market Analysis in Pancreatic Cancer by Geography (USD MN)
  •  Global Car T Cell Therapy Market Analysis in Neuroblasta by Geography (USD MN)
  •  Global Car T Cell Therapy Market Analysis in Breast Cancer by Geography (USD MN)
  •  Global Car T Cell Therapy Market Analysis in Acute Myeloid Leukemia by Geography (USD MN)
  •  Global Car T Cell Therapy Market Analysis in Hepatocellular by Geography (USD MN)
  •  Global Car T Cell Therapy Market Analysis in Carcinoma by Geography (USD MN)
  •  Global Car T Cell Therapy Market Analysis in Colorectal Cancer by Geography (USD MN)
  •  Latin America Car T Cell Therapy Market by Revenue
  •  Middle East & Africa Car T Cell Therapy Market by Revenue
  •  Recent Development in Car T Cell Therapy Industry
  •  Company Market Share Analysis, 2019
 
 * Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

Objectives of Study

  • Define and measure the global market
  • Volume or revenue forecast of the global market and its various sub-segments with respect to main geographies
  • Analyze and identify major market trends along with the factors driving or inhibiting the market growth
  • Study the company profiles of the major market players with their market share
  • Analyze competitive developments

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Why Choose Us

Client First Policy
Excellent Quality
Robust After Sales Support
24/7 Email Support

Clients

Testimonials